154 related articles for article (PubMed ID: 38611590)
1. Incidental Prostate Cancer in Patients Treated for Benign Prostatic Hyperplasia: Analysis from a Contemporary National Dataset.
Bologna E; Licari LC; Franco A; Ditonno F; Manfredi C; De Nunzio C; Antonelli A; De Sio M; Leonardo C; Simone G; Cherullo EE; Autorino R
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611590
[TBL] [Abstract][Full Text] [Related]
2. Is the systematic histological analysis of benign prostatic hyperplasia surgical specimen always necessary?
Coman R; Anract J; Pinar U; Sibony M; Peyromaure M; Delongchamps B
Int Urol Nephrol; 2022 Jul; 54(7):1485-1489. PubMed ID: 35536389
[TBL] [Abstract][Full Text] [Related]
3. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
Herlemann A; Wegner K; Roosen A; Buchner A; Weinhold P; Bachmann A; Stief CG; Gratzke C; Magistro G
World J Urol; 2017 Nov; 35(11):1777-1782. PubMed ID: 28516315
[TBL] [Abstract][Full Text] [Related]
4. Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?
Tonyali S; Ceylan C; Aglamis E; Dogan S; Tastemur S; Karaaslan M
Arch Ital Urol Androl; 2021 Mar; 93(1):31-34. PubMed ID: 33754606
[TBL] [Abstract][Full Text] [Related]
5. Current Trends in Incidence and Management of T1a and T1b Prostate Cancer.
Khan FA; Imam A; Hernandez DJ
Cureus; 2023 Jun; 15(6):e40224. PubMed ID: 37435253
[TBL] [Abstract][Full Text] [Related]
6. Incidence and management of BPH surgery-related urethral stricture: results from a large U.S. database.
Licari LC; Bologna E; Manfredi C; Franco A; Ditonno F; De Nunzio C; Antonelli A; Simone G; De Sio M; Cindolo L; Olweny EO; Cherullo EE; Leonardo C; Autorino R
Prostate Cancer Prostatic Dis; 2024 May; ():. PubMed ID: 38714780
[TBL] [Abstract][Full Text] [Related]
7. Favorable long-term oncological and urinary outcomes of incidental prostate cancer following holmium laser enucleation of the prostate.
Tominaga Y; Sadahira T; Mitsui Y; Maruyama Y; Tanimoto R; Wada K; Munemasa S; Kusaka N; Nishiyama Y; Kurashige T; Nasu Y; Hayata S
Mol Clin Oncol; 2019 Jun; 10(6):605-609. PubMed ID: 31031975
[TBL] [Abstract][Full Text] [Related]
8. Incidental Prostate Cancer Diagnosis Is Common After Holmium Laser Enucleation of the Prostate.
Sakai A; Borza T; Antar A; Richmond E; Allen GO; Knoedler M; Manakas C; Huang W; Gralnek D; Grimes MD
Urology; 2024 Jan; 183():170-175. PubMed ID: 38043905
[TBL] [Abstract][Full Text] [Related]
9. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Ma W; Zeng G; Qi D
J Surg Oncol; 2011 Nov; 104(6):672-8. PubMed ID: 21674503
[TBL] [Abstract][Full Text] [Related]
10. iPCa-Net: A CNN-based framework for predicting incidental prostate cancer using multiparametric MRI.
Wen L; Wang S; Pan X; Liu Y
Comput Med Imaging Graph; 2023 Dec; 110():102309. PubMed ID: 37924572
[TBL] [Abstract][Full Text] [Related]
11. Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression.
Klein C; Marquette T; Capon G; Yacoub M; Alezra E; Bernhard JC; Bladou F; Robert G
Int J Clin Oncol; 2022 Jun; 27(6):1077-1083. PubMed ID: 35333999
[TBL] [Abstract][Full Text] [Related]
12. "In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation.
Porreca A; D'Agostino D; Vigo M; Corsi P; Romagnoli D; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Giampaoli M
Arch Ital Urol Androl; 2020 Jan; 91(4):224-229. PubMed ID: 31937084
[TBL] [Abstract][Full Text] [Related]
13. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
[TBL] [Abstract][Full Text] [Related]
14. Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies.
Luzzago S; Piccinelli ML; Marvaso G; Laukhtina E; Miura N; Schuettfort VM; Mori K; Aydh A; Ferro M; Mistretta FA; Fusco N; Petralia G; Jereczek-Fossa BA; Shariat SF; Karakiewicz PI; de Cobelli O; Musi G
World J Urol; 2022 Feb; 40(2):443-451. PubMed ID: 34687344
[TBL] [Abstract][Full Text] [Related]
15. Incidental Prostate Cancer from Prostate with Benign Biopsies: A Predictive and Survival Analysis from Cohort Study.
Yang CH; Lin YS; Weng WC; Hsu CY; Tung MC; Ou YC
Int J Gen Med; 2022; 15():2807-2816. PubMed ID: 35300134
[TBL] [Abstract][Full Text] [Related]
16. Incidental prostate cancer after transurethral resection of the prostate: analysis of incidence and risk factors in 458 patients.
Porcaro AB; Tafuri A; Inverardi D; Amigoni N; Sebben M; Pirozzi M; Processali T; Rizzetto R; Shakir A; Cerrato C; Tiso L; Panunzio A; DE Michele M; Brunelli M; Siracusano S; Artibani W
Minerva Urol Nephrol; 2021 Aug; 73(4):471-480. PubMed ID: 32003204
[TBL] [Abstract][Full Text] [Related]
17. Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review.
Yoo C; Oh CY; Kim SJ; Kim SI; Kim YS; Park JY; Seong do H; Song YS; Yang WJ; Chung HC; Cho IR; Cho SY; Cheon SH; Hong S; Cho JS
Korean J Urol; 2012 Jun; 53(6):391-5. PubMed ID: 22741046
[TBL] [Abstract][Full Text] [Related]
18. Incidental prostate cancer after holmium laser enucleation of the prostate: Critical analysis of independent risk factors and impact on surgical outcomes.
Porto JG; Blachman-Braun R; Ajami T; Zarli M; Chen R; Furtado T; Marcovich R; Parekh DJ; Shah HN
BJUI Compass; 2024 Mar; 5(3):374-381. PubMed ID: 38481670
[TBL] [Abstract][Full Text] [Related]
19. Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia.
Capogrosso P; Capitanio U; Vertosick EA; Ventimiglia E; Chierigo F; Oreggia D; Moretti D; Briganti A; Vickers AJ; Montorsi F; Salonia A
Urology; 2018 Dec; 122():152-157. PubMed ID: 30138683
[TBL] [Abstract][Full Text] [Related]
20. Serum early prostate cancer antigen (EPCA) as a significant predictor of incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Zeng G; Zhong W
Prostate; 2010 Dec; 70(16):1788-98. PubMed ID: 20583137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
